Kirbylab receives grant for genetic analysis of circulating tumor cells
Kirbylab received NCI support today for several genetic analyses of circulating tumor cells. The work, in collaboration with Weill Cornell Medical College and Cold Spring Harbor Laboratory, will enable sophisticated genetic characterization of circulating tumor cells in advanced prostate cancer patients and enable personalized therapy for these patients following analysis.